SMY: (2R)-3-(1H-indol-3-yl)-1-{4-[(5S)-5-methyl-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]piperazin-1-yl}-1-oxopropan-2-amine
SMY is a Ligand Of Interest in 3OW4 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3OW4_SMY_A_1 | 51% | 34% | 0.176 | 0.932 | 1.02 | 1.7 | 3 | 7 | 2 | 0 | 100% | 1 |
| 3OW4_SMY_B_2 | 48% | 27% | 0.183 | 0.928 | 0.99 | 2.07 | 3 | 15 | 2 | 0 | 100% | 1 |
| 3OW3_SMY_A_401 | 19% | 12% | 0.223 | 0.815 | 1.27 | 2.95 | 5 | 14 | 22 | 0 | 100% | 1 |
